跳至主要内容
临床试验/NCT00991198
NCT00991198已完成2 期

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial

Aria Aesthetics Inc.1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
49
试验地点
1
主要终点
skin grading evaluation of photodamage

研究概览

简要总结

This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects must be female, 25-60 years old in good general health;
  • Subjects must be Fitzpatrick Types I, II, III, IV, V
  • Subjects must be willing to forgo the use of facial cosmetics (e.g. facial moisturizers,creams, foundations, blush, etc.) during the course of the study.
  • Subjects may ONLY use facial regimen of products provided by sponsor(lipstick, lip gloss, and eye mascara permitted).

排除标准

  • Known sensitivity to any of the test material ingredients.
  • Routine high dosage use of anti-inflammatory medications (aspirin, ibuprofen, corticosteroids), immunosuppressive drugs or antihistamine medications (steroid nose drops and/or eye drops are permitted) (one-8lmg or 325mg aspirin okay) (birth control is okay but needs to be reported).
  • Use of topical OTC/Rx drugs or other cosmetics at the test sites.
  • Immunological disorders such as HIV positive and systemic lupus erythematosus (interview only)
  • Participation in any clinical study within the last four weeks.
  • Pregnant or lactating women (interview only).
  • Damaged skin in or around test sites (including sunburn, uneven skin tones, tattoos, scars or other disfiguration of the test site).

研究组 & 干预措施

A

Experimental

Aria Regimens 0.5% conc

干预措施: Topical oxygen (Drug)

B

Experimental

Aria Regimen (5 products) 0.25% conc

干预措施: Topical oxygen (Drug)

C

Placebo Comparator

Aria Regimen Control without O2

干预措施: placebo (Drug)

结局指标

主要结局

skin grading evaluation of photodamage

时间窗: 8 weeks

次要结局

  • stratum corneum hydration (skin capacitance)(8 weeks)
  • bioinstrumental assessment of skin "melanin" lightening, and lesional erythematous sites(8 weeks)
  • bioinstrumental assessment of skin texture, scaliness (desquamation)(8 weeks)
  • punch biopsy histopathologic examination (H&E, and immunohistochemistry for Aquaporin 3, and Filaggrin)(8 weeks)
  • RT-PCR collagenase , and hypoxia-inducible factor-1 alpha(8 weeks)
  • product performance(8 weeks)

研究者

发起方
Aria Aesthetics Inc.
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

The Role of Topically Dissolved Oxygen (TDO) to... | 临床试验